BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29082502)

  • 1. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
    Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
    Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production of 3D tumor spheroids for cancer drug discovery.
    Sant S; Johnston PA
    Drug Discov Today Technol; 2017 Mar; 23():27-36. PubMed ID: 28647083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
    Kochanek SJ; Close DA; Johnston PA
    Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
    Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
    SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
    Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
    SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer.
    Shan F; Close DA; Camarco DP; Johnston PA
    Assay Drug Dev Technol; 2018 Jan; 16(1):27-50. PubMed ID: 29215913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation.
    Das V; Fürst T; Gurská S; Džubák P; Hajdúch M
    J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
    SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
    Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
    PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.
    Kochanek SJ; Close DA; Camarco DP; Johnston PA
    SLAS Discov; 2020 Apr; 25(4):329-349. PubMed ID: 31983262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
    Hagemann J; Jacobi C; Hahn M; Schmid V; Welz C; Schwenk-Zieger S; Stauber R; Baumeister P; Becker S
    Anticancer Res; 2017 May; 37(5):2201-2210. PubMed ID: 28476783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
    Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
    Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
    SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
    Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
    Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity.
    Raghavan S; Mehta P; Horst EN; Ward MR; Rowley KR; Mehta G
    Oncotarget; 2016 Mar; 7(13):16948-61. PubMed ID: 26918944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Drug Dosing Regimens In Vitro Using Real-Time 3D Spheroid Tumor Growth Assays.
    Lal-Nag M; McGee L; Titus SA; Brimacombe K; Michael S; Sittampalam G; Ferrer M
    SLAS Discov; 2017 Jun; 22(5):537-546. PubMed ID: 28298153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
    Singh M; Close DA; Mukundan S; Johnston PA; Sant S
    Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.